Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain
ConditionMulti-Organ Disorder
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age30-70
SponsorIffat Anwar Medical Complex
About this trial
This clinical trial aims to check the safety and efficacy profile of pulsed radiofrequency (RF) neuromodulation combined with leukocyte-rich platelet-rich plasma (PRP) injections for the treatment of refractory low back pain due to multifidus dysfunction. The trial will compare two groups: one receiving standard physical therapy and the other receiving pulsed RF neuromodulation and physiotherapy.
Eligibility criteria
Qualifiers
Refractory low back pain due to multifidus dysfunction.
Pain persisting for more than 6 months despite conventional treatments.
Ability to provide informed consent.
Disqualifiers
Previous spinal surgery within the last year.
Current use of systemic steroids or immunosuppressive medications.
Known bleeding disorders or anticoagulant therapy.
Pregnancy or lactation.
Trial design
Treatments tested in this trial
- Pulsed RF Neuromodulation
- Leukocyte-Rich PRP Injection
- Physiotherapy Alone
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov